Melaseq 1

Melaseq

Australia has the highest rate of melanoma globally, with approximately 17,000 new cases and 1,400 deaths annually. Prevention, early detection, accurate diagnosis and effective treatment offer the best chance of survival.

Clinical Labs is proud to partner with Geneseq Biosciences to announce the innovative, world-first technology of Melaseq Melanoma Genomic Testing to Australian patients. This Australian-developed and owned test uses genomic technology to define the genetic fingerprint of invasive melanoma, aiding doctors to diagnose melanoma more accurately in its early stages.